Purine derivatives as receptor-tyrosine kinase activityinhibitors

Details for Australian Patent Application No. 2006233530 (hide)

Owner Merck Patent GmbH

Inventors Jonczyk, Alfred; Rautenberg, Wilfried; Crassier, Helene; Hoelzemann, Guenter

Agent Davies Collison Cave

Pub. Number AU-A-2006233530

PCT Pub. Number WO2006/108482

Priority 10 2005 017 259.8 14.04.05 DE

Filing date 15 March 2006

Wipo publication date 19 October 2006

International Classifications

C07D 473/30 (2006.01) Heterocyclic compounds containing purine ring systems

A61K 31/522 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

C07D 473/34 (2006.01) Heterocyclic compounds containing purine ring systems

Event Publications

29 November 2007 PCT application entered the National Phase

  PCT publication WO2006/108482 Priority application(s): WO2006/108482

25 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006233535-(LH-indol-7-YL)-( (pyrimidin-2 - YL-amino) methanone derivatives and related compounds as IGF-RL inhibitors for treating cancer

2006233529-Thermal conduction during alkaline extraction